HAYFEVER

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Ledebouriella seseloides, Quantity: 7.083 mg (Equivalent: Ledebouriella seseloides, Qty 17 mg); Asarum sieboldii, Quantity: 5.833 mg (Equivalent: Asarum sieboldii, Qty 14 mg); Glycyrrhiza uralensis, Quantity: 7.083 mg (Equivalent: Glycyrrhiza uralensis, Qty 17 mg; Equivalent: sucrose, Qty 1.214 mg; Equivalent: glucose monohydrate, Qty 1.214 mg); Ligusticum striatum, Quantity: 7.083 mg (Equivalent: Ligusticum striatum, Qty 17 mg); Notopterygium incisium, Quantity: 5.833 mg (Equivalent: Notopterygium incisium, Qty 14 mg); Magnolia liliflora, Quantity: 10.121 mg (Equivalent: Magnolia liliflora, Qty 24.29 mg); Atractylodes macrocephala, Quantity: 8.75 mg (Equivalent: Atractylodes macrocephala, Qty 21 mg); Actaea cimicifuga, Quantity: 7.083 mg (Equivalent: Actaea cimicifuga, Qty 17 mg); Tetrapanax papyrifer, Quantity: 7.083 mg (Equivalent: Tetrapanax papyrifer, Qty 17 mg)

Available from:

Cathay Herbal Laboratories

INN (International Name):

Actaea cimicifuga,Asarum sieboldii,Atractylodes macrocephala,Glycyrrhiza uralensis,Ledebouriella seseloides,Ligusticum striatum,

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: maize starch

Administration route:

Oral

Therapeutic indications:

Traditionally used in Chinese medicine to dispel/expel/extinguish/disperse/clear wind-coldness ; Traditionally used in Chinese medicine to Unblock/clear nasal passages

Product summary:

Visual Identification: ;

Authorization status:

Licence status A

Authorization date:

2004-09-03